Sartorius

Lentiviruses are growing in the advanced therapy landscape. Experts at Sartorius discuss the unique challenges that come with their production

How digitalization will revolutionize the way we develop and optimize bioprocesses.

Understanding AAV production and characterization processes – and establishing strategies for success.

Sartorius shares its vision for better, faster, and cheaper bioprocessing.

Experts from Sartorius give advice on the next generation processes and facilities for mRNA manufacture.

Single-use technology continues to evolve; single-use bags are now a robust alternative to using bottles in freeze and thaw.

With the threat of COVID-19, vaccine developers needed to enter clinical development and scale-up at unprecedented speed.

Manufacturers must look to ease the headaches associated with the manufacture of mRNA-based products.

Biopharma companies are rapidly making changes to their manufacturing strategies – and flexible downstream unit operation solutions are key.

What have we learned from the pandemic and how can we address the coming challenges?

Biopharmaceutical drug products, or biologics, are fast becoming an essential branch of the healthcare industry.

When it comes to mixing operations for bioprocessing, quality and efficiency are critical – and the equipment you choose can dramatically affect both.

Nutri-T offers exceptional performance with cells starting at low initial seeding concentrations.

The CHO Platform Service package combines Sartorius’ technologies and services as one integrated solution that accelerates your program